BrainCheck

Dr. Cho is a St. Louis-based psychiatrist specializing in older adults. He integrated BrainCheck into his practice to bring objective, benchmarked cognitive data into a field that has long relied on intuition alone.

In just over a year, Dr. Cho completed 215 assessments, gaining stronger diagnostic confidence.

"With BrainCheck, you're going to have better clinical outcomes. It gives you more information, some patients even find it fun to use. This is a win-win-win."

Read Dr. Cho's full story → https://bit.ly/3NbgJ5i

The National Institutes of Health (NIH) recently announced findings that could fundamentally change how we think about preventing Alzheimer's disease and related dementias (ADRD). A 20-year longitudinal study has demonstrated that a specific type of cognitive training may reduce ADRD risk by 25% over two decades.

This research opens the door to practical, accessible interventions that could change how we approach brain health for millions of people.

Bin Huang, BrainCheck's Principal Scientist, breaks down the findings –– what makes the study unique, clinical benefits, questions, recommendations, and more.

Read the article here: https://bit.ly/4rBYIv2

Cognitive impairment affects an estimated 40–60% of people living with multiple sclerosis, yet routine cognitive monitoring is still not consistently integrated into MS care.

A new clinical case study from Doctors Hospital at Renaissance (DHR Health) highlights how neurologist Dr. Roberto Alejandro Cruz, MD implemented standardized cognitive assessment across a high-volume neurology practice using BrainCheck Assess.

Key elements of the implementation:
• 1,000+ cognitive assessments completed in 2025
• Baseline testing at diagnosis with annual longitudinal monitoring
• Use across MS, Parkinson’s disease, and dementia populations
• Spanish-language assessment supporting a predominantly Hispanic patient population

As disease-modifying therapies reduce relapse activity, clinicians are increasingly focused on detecting progression independent of relapse activity (PIRA) — where cognitive decline occurs even when MRI findings remain stable.

Establishing objective cognitive baselines and tracking within-patient change may help clinicians identify subtle functional decline earlier.

Read the clinical case study: https://bit.ly/3OUInnD

We’re thrilled to announce that BrainCheck has raised $13 million in Series A financing to accelerate the expansion of our AI-Enabled Cognitive Care Platform!

This funding will empower us to:
• Deepen workflow integrations and longitudinal monitoring
• Support scalable, enterprise-wide cognitive care infrastructure
• Advance AI-assisted clinical tools for earlier detection and care pathways
• Partner with collaborative care organizations to bring structured cognitive care into more clinical practices nationwide

Thank you to our investors and partners for believing in our mission to transform cognitive care and improve outcomes for patients and providers. We’re just getting started! 💡🧠

Read the announcement: https://hubs.ly/Q044RKBH0